MP81-16 PERIOPERATIVE AND EARLY ONCOLOGICAL OUTCOMES FOLLOWING ROBOT ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER: A MULTI-INSTITUTIONAL STUDY

Abstract

You have accessJournal of UrologySexual Function/Dysfunction: Penis/Testis/Urethra: Benign Disease & Malignant Disease II1 Apr 2016MP81-16 PERIOPERATIVE AND EARLY ONCOLOGICAL OUTCOMES FOLLOWING ROBOT ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER: A MULTI-INSTITUTIONAL STUDY Haidar Abdul-Muhsin, Michael Marshall, Sean Stroup, James L'esperance, Michael Woods, James Porter, and Erik Castle Haidar Abdul-MuhsinHaidar Abdul-Muhsin More articles by this author , Michael MarshallMichael Marshall More articles by this author , Sean StroupSean Stroup More articles by this author , James L'esperanceJames L'esperance More articles by this author , Michael WoodsMichael Woods More articles by this author , James PorterJames Porter More articles by this author , and Erik CastleErik Castle More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.2069AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To evaluate the perioperative outcomes and postoperative complication rates for robot assisted retroperitoneal lymph node dissection (RA-RPLND) in a large multi-Institutional cohort. METHODS After individual institutional review board approval in four participating institutions, the data of all testicular cancer patients treated with RA-RPLND at these tertiary institutions were collected and retrospectively analyzed. The procedures were performed by a single robotic surgeon at each participating institution. All demographic, Intraoperative variables, post-operative pathological outcomes and complications were reported. Additionally, Recurrence rates were reported at then end of follow up. RESULTS There were 103 patients who underwent RA-RPLND. The mean patients age was 29.6 years (SD 9.7), mean BMI was 26.4 Kg/m2 (SD 5.1). Bilateral Full template dissection was performed in 65 (63.1%) patients compared to 36 patients (35%) who had modified templates of dissection. Nerve sparing was attempted in 68 (66%) patients. There were 70 (68%) patients who underwent primary RA-RPLND compared to 33 (32%) patients who received previous chemotherapy. Mean operative time was 339 min (SD 108). Estimated blood loss was 244.1 ml (SD 486). Length of postoperative hospital stay was 2.1 days (SD 1.5). There were six conversions (5.8%) to open RPLND. Postoperatively, there were 28 total complications (Grade I=22, II=5, IIIB=1). From oncological point of view, mean lymph node (LN) yield was 24.1 LNs (SD 10.8) with positive LN identified in 35 patients (33.9%). Among the primary RARPLND, adjuvant chemotherapy was given to 21.4% (3/14) of pIIA, 50% (3/6) of pIIB and 50% of pIIC patients. There were five lung recurrences (4.8%) identified at a mean follow up of 26.9 months (SD 22.4). No in field recurrences were identified CONCLUSIONS To our knowledge this study represents the largest study of RA-RPLND outcomes in testicular cancer patients. It demonstrates that this procedure is safe and reproducible. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e1059 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Haidar Abdul-Muhsin More articles by this author Michael Marshall More articles by this author Sean Stroup More articles by this author James L'esperance More articles by this author Michael Woods More articles by this author James Porter More articles by this author Erik Castle More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...